Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

207
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
207
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

238
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
238
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.9K
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

245
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
245
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

308
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemometrics-Assisted Identification of Anti-Inflammatory Compounds from the Green Alga <i>Klebsormidium flaccidum</i> var. <i>zivo</i>.

Molecules (Basel, Switzerland)·2020
Same author

Two undescribed paradol-related specialized metabolites from <i>Aframomum melegueta</i>.

Natural product research·2020
Same author

Three undescribed monoterpene rhamnosides from the aerial parts of <i>Vangueria agrestis</i>.

Natural product research·2020
Same author

Xuetonglactones A-F: Highly Oxidized Lanostane and Cycloartane Triterpenoids From <i>Kadsura heteroclita</i> Roxb. Craib.

Frontiers in chemistry·2020
Same author

Bioassay guided isolation of mosquito biting deterrent compounds from Strumpfia maritima.

Pest management science·2020
Same author

The scoop on brain health dietary supplement products containing huperzine A.

Clinical toxicology (Philadelphia, Pa.)·2020

Related Experiment Video

Updated: Jan 19, 2026

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
04:54

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq

Published on: March 19, 2021

5.1K

Roadmap for Quality by Design Implementation for Dietary Supplements.

Mohamed A Albadry1, Ikhlas A Khan1

  • 1University of Mississippi, School of Pharmacy, Department of BioMolecular Sciences, Division of Pharmacognosy and National Center for Natural Products Research, 3011 Thad Cochran Research Center, University, MS 38677.

Journal of AOAC International
|September 28, 2019
PubMed
Summary
This summary is machine-generated.

Quality by Design (QbD) in dietary supplements requires understanding critical quality attributes (CQAs) and raw material variability. This review highlights techniques for botanical raw material identification and characterization to aid QbD implementation.

More Related Videos

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K

Related Experiment Videos

Last Updated: Jan 19, 2026

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
04:54

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq

Published on: March 19, 2021

5.1K
Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K

Area of Science:

  • Dietary Supplements and Nutraceuticals
  • Quality by Design (QbD) Principles
  • Botanical Raw Material Characterization

Background:

  • Growing adoption of Quality by Design (QbD) in the dietary supplements industry.
  • QbD implementation faces challenges due to botanical raw material variability and defining critical quality attributes (CQAs).

Purpose of the Study:

  • To address challenges in QbD implementation for herbal drugs and dietary supplements.
  • To provide an overview of techniques for identifying and characterizing botanical raw materials.

Main Methods:

  • Review of various techniques for botanical raw material identification.
  • Review of methods for characterization of botanical raw materials.
  • Analysis of the relationship between manufacturing processes, CQAs, and raw material variability.

Main Results:

  • Identified numerous techniques applicable to botanical raw material analysis.
  • These techniques support the successful implementation of QbD for botanicals and dietary supplements.
  • Understanding CQA relationships with supplement properties and manufacturing is crucial.

Conclusions:

  • Effective QbD implementation requires addressing botanical quality variations and CQA definition.
  • Collaboration between academia, industry, and regulatory bodies is essential for integrating QbD into current regulations.
  • Further research and discussion are needed to refine QbD strategies for dietary supplements.